Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in France / NCT07392801
Recruiting Not applicable

AGE Accumulation in Patients on Long-term Parenteral Nutrition

NCT07392801 · tracked via the Priya Life Science France tracker
Sponsor
University Hospital, Bordeaux
Phase
Not applicable
Started
2026-07-22
Last updated
2026-07-24

Condition(s) studied

Chronic Intestinal InsufficiencyAdvanced Glycation and ProductsParenteral Nutrition

Investigational drug(s) / intervention(s)

Non-invasive skin AGE measurements

Non-invasive skin AGE measurements: Non-invasive skin AGE measurements at baseline, 6 and 12 months; collection and analysis of parenteral nutrition bag samples; routine metabolic assessments; dietary records, glucose holter, plasma glycated hemoglobin and fructosamine assays.

Study summary

This prospective and observational study aims to evaluate the accumulation of advanced glycation end-products (AGEs) in adult and pediatric patients starting long-term parenteral nutrition, by non-invasive skin AGE measurements over a 12-month follow-up.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Patients (adults and children, all ages) initiating long-term parenteral nutrition * Followed at CHU de Bordeaux or Robert Debré Hospital (APHP) * Covered by French Social Security system * Written informed consent obtained from patient (if adult) or legal guardian (if minor) Exclusion Criteria: * Fitzpatrick skin type ≥ V (darker skin tones) * Forearm tattoos at the site of measurement * For patients included under 1 year of age: patients born prematurely (before 37 weeks of amenorrhea) * Pregnant or breastfeeding women.

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
CHU de Bordeaux-Hôpital des enfants GH Pellegrin Bordeaux France Not Yet Recruiting
AP-HP - Hopital Robert Debré Paris France Not Yet Recruiting
CHU de Bordeaux - Hôpital Haut Lévêque Pessac France Recruiting

More University Hospital, Bordeaux trials in France

Prevalence of Alpha-1 Antitrypsin Deficiency in Non-Cirrhotic Liver Cancer Starting soon
Prospective Cohort Study of Neurogenetic Diseases Recruiting
Validation of Multi-contrast, High-resolution Cardiac Magnetic Resonance Imaging Recruiting
Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk Recruiting
Patient-Perceived Symptoms at the Center of Obstructive Sleep Apnea (OSA) Management: Validation of the French Version of the Patient-Reported Apnea Questionnaire (PRAQ) Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07392801 on ClinicalTrials.gov ↗ ← All trials in France